Home › Compare › LMLLF vs QYLD

LMLLF vs QYLD: Dividend Comparison 2026

LMLLF yields 26315.79% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LMLLF wins by $802085897127229390848.00M in total portfolio value
10 years
LMLLF
LMLLF
● Live price
26315.79%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$802085897127229390848.00M
Annual income
$796,134,651,160,688,600,000,000,000.00
Full LMLLF calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — LMLLF vs QYLD

📍 LMLLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLMLLFQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LMLLF + QYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
LMLLF pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LMLLF
Annual income on $10K today (after 15% tax)
$2,236,842.11/yr
After 10yr DRIP, annual income (after tax)
$676,714,453,486,585,300,000,000,000.00/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, LMLLF beats the other by $676,714,453,486,585,300,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LMLLF + QYLD for your $10,000?

LMLLF: 50%QYLD: 50%
100% QYLD50/50100% LMLLF
Portfolio after 10yr
$401042948563614695424.00M
Annual income
$398,067,325,580,344,300,000,000,000.00/yr
Blended yield
99.26%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LMLLF buys
0
QYLD buys
0
No recent congressional trades found for LMLLF or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLMLLFQYLD
Forward yield26315.79% ✓11.92%
Annual dividend / share$2.00$2.04 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$802085897127229390848.00M ✓$25.4K
Annual income after 10y$796,134,651,160,688,600,000,000,000.00 ✓$5,659.31
Total dividends collected$801694023521105215488.00M ✓$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: LMLLF vs QYLD ($10,000, DRIP)

YearLMLLF PortfolioLMLLF Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$2,642,279$2,631,578.95$10,352$1,192.36+$2.63M → LMLLF
2$652,674,496$649,847,257.10$10,830$1,347.57+$652.66M → LMLLF
3$150,717,093,655$150,018,731,944.79$11,460$1,539.07+$150717.08M → LMLLF
4$32,537,594,543,311$32,376,327,253,099.92$12,275$1,777.84+$32537594.53M → LMLLF
5$6,567,124,460,012,792$6,532,309,233,851,450.00$13,323$2,078.95+$6567124460.00M → LMLLF
6$1,239,202,870,261,231,900$1,232,176,047,089,018,000.00$14,667$2,463.34+$1239202870261.22M → LMLLF
7$218,624,156,631,620,120,000$217,298,209,560,440,600,000.00$16,396$2,960.57+$218624156631620.09M → LMLLF
8$36,062,384,982,353,154,000,000$35,828,457,134,757,322,000,000.00$18,631$3,612.97+$36062384982353152.00M → LMLLF
9$5,561,912,118,262,444,000,000,000$5,523,325,366,331,326,000,000,000.00$21,548$4,482.15+$5561912118262444032.00M → LMLLF
10$802,085,897,127,229,400,000,000,000$796,134,651,160,688,600,000,000,000.00$25,398$5,659.31+$802085897127229390848.00M → LMLLF

LMLLF vs QYLD: Complete Analysis 2026

LMLLF — Stock

Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also imports and distributes medical cannabis to pharmacies in Germany and rest of the European Union; and owns and operates Super Smart, an entity building to elevate the use of functional mushrooms and psilocybin mushrooms. In addition, the company engages in the researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in normal, diseased, and altered states of consciousness, as well as an agreement with Southwest Research Institute for initiating non-clinical and clinical manufacturing of cepharanthine; and clinical trial agreement with Johns Hopkins University to conduct a clinical study comparing acute and enduring psychological and neural effects of DMT and an undisclosed potently active comparator molecule. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. The company is based in Toronto, Canada.

Full LMLLF Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this LMLLF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LMLLF vs SCHDLMLLF vs JEPILMLLF vs OLMLLF vs KOLMLLF vs MAINLMLLF vs XYLDLMLLF vs JEPQLMLLF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.